母亲癫痫与子代长期死亡率:一项全国性队列研究
该研究基于丹麦1981至2016年全国登记数据,纳入1,862,474名单胎活产及死产儿,评估母亲癫痫及孕期使用抗癫痫发作药物与子代死亡率的关系。母亲癫痫子代总体死亡率升高(MRR=1.46,95%CI:1.23-1.71),超额死亡仅见于出生后第一年,且仅限于孕期使用抗癫痫发作药物的母亲子代。2000年及以后出生的子代中,第一年超额死亡不再明显。
要点
- 母亲癫痫子代总体死亡率升高(MRR=1.46),超额死亡仅见于出生后第一年。
- 自然死亡增加(MRR=1.50),非自然死亡未达统计学显著(MRR=1.38,95%CI:0.84-2.14)。
- 超额死亡仅见于孕期使用抗癫痫发作药物的母亲子代(MRR=1.51),未使用者无显著升高(MRR=0.97)。
核心结论
- 1981至1999年期间,癫痫母亲子代出生后第一年死亡风险增加,但这一风险未延伸至2000年后出生的儿童。
- 作者认为,未来关于母亲癫痫对子代健康影响的回顾性研究应考虑这一差异。
研究设计与样本
- 基于人群的队列研究,纳入丹麦1981至2016年所有活产及死产单胎。
- 通过全国登记系统获取妊娠特征、癫痫诊断、抗癫痫发作药物使用及死亡信息,采用对数线性泊松回归估计调整死亡率比(MRR)。
- 队列共包含1,862,474名儿童;随访期间12,026名活产儿死亡,其中170名(1.4%)为癫痫母亲子代。
主要发现
- 癫痫母亲子代总体死亡率较无癫痫母亲子代升高(MRR=1.46,95%CI:1.23-1.71),超额死亡仅见于出生后第一年。
- 自然死亡升高(MRR=1.50,95%CI:1.25-1.78),非自然死亡未达统计学显著(MRR=1.38,95%CI:0.84-2.14)。
- 孕期使用抗癫痫发作药物的癫痫母亲子代死亡率升高(MRR=1.51,95%CI:1.00-2.17),孕期未使用者未见升高(MRR=0.97,95%CI:0.69-1.31)。
- 限定于2000年及以后出生的儿童时,癫痫母亲子代出生后第一年的超额死亡不再明显。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We examined how maternal epilepsy and use of antiseizure medications in pregnancy was associated with offspring mortality. METHODS: This population-based cohort study included all live- and stillborn singletons in Denmark between 1981 and 2016. We used nation-wide registers to retrieve information on pregnancy characteristics, epilepsy diagnoses, use of antiseizure medications, and mortality. Adjusted mortality rate ratios (MRR) were estimated using log-linear Poisson regression. RESULTS: The cohort consisted of 1,862,474 children. In total, 12,026 live-born children died during follow-up, of whom 170 (1.4%) were offspring of mothers with epilepsy. Overall mortality was increased in offspring of mothers with epilepsy compared to offspring of mothers without epilepsy (MRR = 1.46, 95% CI: 1.23-1.71), driven by an excess mortality only in the first year of life. Mortality was increased for natural deaths (MRR = 1.50, 95% CI: 1.25-1.78) but not from unnatural deaths (MRR = 1.38, 95% CI: 0.84-2.14), and only in offspring of women with epilepsy who used antiseizure medications during pregnancy (MRR = 1.51, 95% CI: 1.00-2.17), but not in offspring of women with epilepsy who did not use antiseizure medications while pregnant (MRR = 0.97, 95% CI: 0.69-1.31). When analyses were restricted to children born from 2000 and onwards, the excess mortality that was observed in the first year of life among children of mothers with epilepsy, was no longer evident. INTERPRETATION: During the 1981 to 1999 epoch, offspring of women with epilepsy were at increased risk of dying in the first year of life. However, this risk did not extend to children born after 2000. Future retrospective studies of the effects of maternal epilepsy on the health of the offspring should take this difference into account. ANN NEUROL 2022;91:455-465.
引用
- Christensen J, Antonsen S, Sun Y, et al. Maternal Epilepsy and Long-term Offspring Mortality: A Nationwide Cohort Study. Ann Neurol. 2022. PMID: 35148430. doi:10.1002/ana.26315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。